An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
Speakers are: Ch. A. P. Rameswara Rao, National President, BDMAI; Dr. Paidi Yella Reddy, Founder, President & CEO, Sapala Organics; K. V. Rama Gopal, Site Manager & Executive Director, Clariant India; Dr. K. Nagaiah, Chief Scientist, CSIR - Indian Institute of Chemical Technology, Hyderabad; Dr. Satyanarayana Thirunahari, Senior General Manager - Process Safety & Engineering, Laurus Labs; and Yadavendra Shalgaonkar, Assistant General Manager - Tube Sales, Alleima India
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Subscribe To Our Newsletter & Stay Updated
